Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia

Abstract

Background. Hyperlipidemia, due to the practice of unhealthy lifestyles of modern people, has been a disturbance to a large portion of population worldwide. Recently, several scholars have turned their attention to Chinese medicine (CM) to seek out a lipid-lowering approach with high efficiency and low toxicity. This study aimed to explore the mechanism of Huatan Jiangzhuo decoction (HTJZD, a prescription of CM) in the treatment of hyperlipidemia and to determine the major regulation pathways and potential key targets involved in the treatment process. Methods. Data on the compounds of HTJZD, compound-related targets (C-T), and known disease-related targets (D-T) were collected from databases. The intersection targets (I-T) between C-T and D-T were filtered again to acquire the selected targets (S-T) according to the specific index. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, as well as network construction, were applied to predict the putative mechanisms of HTJZD in treating hyperlipidemia. Thereafter, an animal experiment was conducted to validate the therapeutic effect of HTJZD. In addition, regulated differentially expressed genes (DEGs) were processed from the RNA sequencing analysis results. Common genes found between regulated DEGs and S-T were analyzed by KEGG pathway enrichment to select the key targets. Lastly, key targets were validated by real-time quantitative reverse transcription PCR (qRT-PCR) analysis. Results. A total of 210 S-T were filtered out for enrichment analysis and network construction. The enrichment results showed that HTJZD may exert an effect on hyperlipidemia through the regulation of lipid metabolism and insulin resistance. The networks predict that the therapeutic effect of HTJZD may be based on the composite pharmacological action of these active compounds. The animal experiment results verify that HTJZD can inhibit dyslipidemia in rats with hyperlipidemia, suppress lipid accumulation in the liver, and reverse the expression of 202 DEGs, which presented an opposite trend in the model and HTJZD groups. Six targets were selected from the common targets between 210 S-T and 202 regulated DEGs, and the qRT-PCR results showed that HTJZD could effectively reverse Srebp-1c, Cyp3a9, and Insr mRNA expression (P < 0.01). Conclusion. In brief, network pharmacology predicted that HTJZD exerts a therapeutic effect on hyperlipidemia. The animal experimental results confirmed that HTJZD suppressed the pathological process induced by hyperlipidemia by regulating the expression of targets involved in lipid metabolism and insulin resistance.

Analysis of the mechanism of action of quercetin in the treatment of hyperlipidemia based on metabolomics and intestinal flora

“…The normal control group was given maintenance feed while the other group was fed with a high-fat diet (containing 49.18% maintenance feed, 20% sucrose, 15% lard, 12.5% casein, 1.2% cholesterol, 1.3% calcium hydrogen phosphate, 0.5% stone powder, 0.2% sodium cholate and 0.12% propylthiouracil as prepared by Hunan Slake Jingda Experimental Animal Co., Ltd). 20 After feeding the rats for 14 days, the rats were anesthetized by intraperitoneal injection of 5% chloral hydrate, and blood samples were collected from the fundus venous plexus to check whether TC, TG, LDL-C, and HDL-C levels are significantly different from the normal group ( P < 0.05), indicating that the model is successful.…”

“…After 30 days of drug intervention, all animals were sacrificed for blood sample and liver sample collection. 20…”

Efficacy of Poria cocos and Alismatis rhizoma against diet-induced hyperlipidemia in rats based on transcriptome sequencing analysis

“…At the end of the fourth week, after the rats had fasted for 12 h, blood lipids indices, including TC, TG, LDL-C, and HDL-C, were analyzed to evaluate whether the model was successfully established. The model evaluation criteria were assessed as described previously 26 .…”

“…Following the animal ethics principle of minimizing harm to animals, the control and model groups of rats used in this study were shared with the two groups previously described in published literature 26 . Permissions was obtained from the previous publisher.…”